Cargando…
The Memory Benefit to Aged APP/PS1 Mice from Long-Term Intranasal Treatment of Low-Dose THC
THC has been used as a promising treatment approach for neurological disorders, but the highly psychoactive effects have largely warned off many scientists from pursuing it further. We conducted an intranasal treatment using low-dose THC on 12-month-old APP/PS1 mice daily for 3 months to overcome an...
Autores principales: | Fihurka, Oksana, Hong, Yuzhu, Yan, Jiyu, Brown, Breanna, Lin, Xiaoyang, Shen, Ning, Wang, Yanhong, Zhao, Haohan, Gordon, Marcia N., Morgan, David, Zhou, Qingyu, Chang, Ping, Cao, Chuanhai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029288/ https://www.ncbi.nlm.nih.gov/pubmed/35457070 http://dx.doi.org/10.3390/ijms23084253 |
Ejemplares similares
-
Low-Dose Delta-9-Tetrahydrocannabinol as Beneficial Treatment for Aged APP/PS1 Mice
por: Wang, Yanhong, et al.
Publicado: (2022) -
Multi-Targeting Intranasal Nanoformulation as a Therapeutic for Alzheimer’s Disease
por: Fihurka, Oksana, et al.
Publicado: (2023) -
Measurement of Δ(9)THC and metabolites in the brain and peripheral tissues after intranasal instillation of a nanoformulation
por: Upadhyay, Gunjan, et al.
Publicado: (2023) -
Data on enrichment of chitosan nanoparticles for intranasal delivery of oligonucleotides to the brain
por: Sava, Vasyl, et al.
Publicado: (2020) -
Key Features in the Design and Function of Nanocarriers for Intranasal Administration of Gene Therapy in Huntington Disease
por: Fihurka, Oksana, et al.
Publicado: (2023)